|Author:||Institute of Medicine,Division of Health Care Services|
|Title:||Hip Fracture: Setting Priorities for Effectiveness Research (Institute of Medicine : Report of a Study)|
|Format:||lit txt lrf azw|
|ePUB size:||1812 kb|
|FB2 size:||1982 kb|
|DJVU size:||1350 kb|
|Category:||Medicine and Health Sciences|
|Publisher:||National Academies Press (February 1, 1990)|
Institute of Medicine. Washington, DC: The National Academies Press.
General Note: Committee chair: Kenneth I. Shine. On this site it is impossible to download the book, read the book online or get the contents of a book. The administration of the site is not responsible for the content of the site. The data of catalog based on open source database. All rights are reserved by their owners.
Your use of the site and services is subject to these policies and terms. Results from Google Books.
Book Info Institute of Medicine. Report of the Committee on Methods for Setting Priorities for Guidelines Development, Division of Health Care Services, Institute of Medicine.
Act in time to heart attack signs a presentation of the National Heart, Lung, and Blood Institute of the National Institutes of Health, in partnership with the American Heart Association, American Red Cross, National Council on the Aging. Zijpijn in de Borst rede : uitgesproken bij de aanvaarding van het ambt van hoogleraar in de Klinische Cardiologie, in het bijzonder de Acute Coronaire Syndromen, aan de Universiteit van Amsterdam op vrijdag 6 februari 2009, by: Winter, Robbert J. de.
The Institute of Medicine will deliver its report by the end of June 2009, and the FCC-CER has been appointed. It recently released its draft definition of CER:1.
A new study from the Institute of Medicine (IOM; Washington) presents important information to help industry and policy-making bodies set domestic vaccine priorities for the future. Vaccines for the 21st Century: A Tool for Decisionmaking, commissioned by the National Institute of Allergy and Infectious Diseases (NIAID; Bethesda, MD), employs a new quantitative model to compare the cost and health benefits of developing more than two dozen different candidate vaccines, including, for the first time, therapeutic vaccines against chronic diseases
2 Institute of Medicine. Tropical Medicine & International Health, 2009, 14(8): 930–939.
The Committee on Comparative Effectiveness.